AI assistant
CORCEPT THERAPEUTICS INC — Director's Dealing 2021
May 21, 2021
30681_dirs_2021-05-20_a5e1ab18-52e8-498c-94ea-ecca9895dd09.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-05-18
Reporting Person: BAKER G LEONARD JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-18 | Common Stock | M | 30000.0000 | $6.5500 | Acquired | 1026838.0000 | Direct |
| 2021-05-18 | Common Stock | M | 30000.0000 | $4.4200 | Acquired | 1056838.0000 | Direct |
| 2021-05-18 | Common Stock | M | 30000.0000 | $4.0500 | Acquired | 1086838.0000 | Direct |
| 2021-05-18 | Common Stock | M | 30000.0000 | $1.7400 | Acquired | 1116838.0000 | Direct |
| 2021-05-18 | Common Stock | M | 30000.0000 | $1.7400 | Acquired | 1146838.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-18 | Stock Option (Right To Buy) | $1.7400 | M | 30000.0000 | Disposed | 2024-05-08 | Common Stock (30000.0000) | Direct |
| 2021-05-18 | Stock Option (Right To Buy) | $1.7400 | M | 30000.0000 | Disposed | 2023-05-17 | Common Stock (30000.0000) | Direct |
| 2021-05-18 | Stock Option (Right To Buy) | $4.4200 | M | 30000.0000 | Disposed | 2021-05-19 | Common Stock (30000.0000) | Direct |
| 2021-05-18 | Stock Option (Right To Buy) | $4.0500 | M | 30000.0000 | Disposed | 2022-06-13 | Common Stock (30000.0000) | Direct |
| 2021-05-18 | Stock Option (Right To Buy) | $6.5500 | M | 30000.0000 | Disposed | 2025-06-18 | Common Stock (30000.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3208303.0000 | Indirect |
| Common Stock | 955055.0000 | Indirect |
Footnotes
F1: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.
F2: As described in footnote (1), includes an aggregate of 150,000 shares held for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of such shares.
F3: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
F4: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.
F5: Immediately exercisable.